2007
DOI: 10.1001/archneur.64.8.1176
|View full text |Cite
|
Sign up to set email alerts
|

Phenotypic Study in 40 Patients With Dysferlin Gene Mutations

Abstract: To describe the phenotypic spectrum of dysferlin (DYSF) gene mutations (which cause dysferlinopathies, autosomal recessive muscular dystrophies) in patients with a dysferlin protein deficiency. Design: Clinical, biological, and pathological data from 40 patients were reviewed. The diagnosis of dysferlinopathy was based on the absence or strong reduction of dysferlin in muscle, and confirmed by mutational screening of the DYSF gene. Setting: Two French neuromuscular diseases centers (in Paris and Marseilles). R… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

11
221
5
26

Year Published

2011
2011
2024
2024

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 242 publications
(263 citation statements)
references
References 24 publications
11
221
5
26
Order By: Relevance
“…Different from other limb girdle muscular dystrophies, subacute presentation may occur in about 25% of the patients. It may simulate both clinically and histologically inflammatory myopathies such as polymyositis 38 , as observed on a muscle biopsy of a 16 years old dysferlin-negative female patient ( Figure 2C). …”
Section: Dysferlinopathy (Lgmd2b)mentioning
confidence: 87%
See 4 more Smart Citations
“…Different from other limb girdle muscular dystrophies, subacute presentation may occur in about 25% of the patients. It may simulate both clinically and histologically inflammatory myopathies such as polymyositis 38 , as observed on a muscle biopsy of a 16 years old dysferlin-negative female patient ( Figure 2C). …”
Section: Dysferlinopathy (Lgmd2b)mentioning
confidence: 87%
“…Rare patients may present predominant anterior compartment distal weakness 39 . Besides that, there are oligo symptomatic patients with creatine kinase increase 38 . Usually, there is lower limb weakness that, after a period of about 6 years, is followed by upper limb weakness, but this interval may vary from 1 to 16 years 35 .…”
Section: Dysferlinopathy (Lgmd2b)mentioning
confidence: 99%
See 3 more Smart Citations